Skip to main content
. 2022 Oct 24;11(4):67. doi: 10.3390/antib11040067

Figure 5.

Figure 5

Kinetic-pharmacodynamic model characterization of mRNAs encoding 3 HIV antibodies. Extrapolated serum levels of bnAbs after 1 mg/kg mRNA dosing up to 90 days following infusion. bnAb, broadly neutralizing antibody; Fc, crystallizable fragment; HIV, human immunodeficiency virus; IgG, immunoglobulin G; scFv, single-chain variable fragment.